These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 1472781

  • 1. [The inhibitor effect of the ampicillin-sulbactam combination on Enterobacteriaceae resistant to ampicillin].
    Poiată A, Diculencu D, Buiuc D.
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(1-2):67-9. PubMed ID: 1472781
    [No Abstract] [Full Text] [Related]

  • 2. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C, García A, Urrea R, del Solar E, Bello H, Zemelman R.
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [Abstract] [Full Text] [Related]

  • 3. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.
    Siu LK, Cheng WL, Ho PL, Ng WS, Chau PY, Lo JY.
    APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419
    [Abstract] [Full Text] [Related]

  • 4. In vitro effect of ampicillin/sulbactam on Acinetobacter species.
    Hostacká A.
    Microbios; 2001 Sep; 106 Suppl 2():97-104. PubMed ID: 11548205
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Fabbri A, Tacchella A, Belli ML, Losurdo G.
    Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 8. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.
    Pfaller MA, Barry AL, Fuchs PC, Gerlach EH, Hardy DJ, McLaughlin JC.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):356-62. PubMed ID: 8354303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.
    Prabhakaran K, Harris EB, Randhawa B, Hastings RC.
    Microbios; 1992 May; 72(291):137-42. PubMed ID: 1287401
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
    Greenberg RN, Baker M, Meade DW, Chang Y, Danko LS.
    J Antimicrob Chemother; 1993 Dec; 32(6):912-3. PubMed ID: 8144438
    [No Abstract] [Full Text] [Related]

  • 14. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 Dec; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF, Wildfeuer A.
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
    Varaldo PE, Ripa S, Nicoletti G, Covelli I, Satta G, Carlone N, Fontana R.
    Chemotherapy; 1990 Oct; 36(2):141-6. PubMed ID: 2178890
    [Abstract] [Full Text] [Related]

  • 19. Restricting the use of ampicillin-sulbactam.
    Zavascki AP, Sandri AM.
    J Hosp Infect; 2004 Feb; 56(2):165-6. PubMed ID: 15019231
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.